These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

324 related items for PubMed ID: 7582386

  • 1. Effects of bezafibrate and of 2 HMG-CoA reductase inhibitors on lipoprotein (a) level in hypercholesterolemic patients.
    Branchi A, Rovellini A, Fiorenza AM, Sommariva D.
    Int J Clin Pharmacol Ther; 1995 Jun; 33(6):345-50. PubMed ID: 7582386
    [Abstract] [Full Text] [Related]

  • 2. Effect of three fibrate derivatives and of two HMG-CoA reductase inhibitors on plasma fibrinogen level in patients with primary hypercholesterolemia.
    Branchi A, Rovellini A, Sommariva D, Gugliandolo AG, Fasoli A.
    Thromb Haemost; 1993 Aug 02; 70(2):241-3. PubMed ID: 8236126
    [Abstract] [Full Text] [Related]

  • 3. [Effectiveness, tolerance and safety of simvastatin in comparison with bezafibrate in treatment of hypercholesterolemia].
    Lechleitner M, Sailer S, Irsigler H, Klein W, Patsch JR.
    Wien Med Wochenschr; 1995 Aug 02; 145(21):577-83. PubMed ID: 8560901
    [Abstract] [Full Text] [Related]

  • 4. [Therapy of hypercholesterolemia after heart transplantation with the HMG-CoA reductase inhibitor simvastatin in long-term follow-up].
    Wenke K, Thiery J, Meiser B, Arndtz N, Seidel D, Reichart B.
    Z Kardiol; 1995 Feb 02; 84(2):130-6. PubMed ID: 7717016
    [Abstract] [Full Text] [Related]

  • 5. Effects of fluvastatin, a new inhibitor of HMG-CoA reductase, and niceritrol on serum lipids, lipoproteins and cholesterol ester transfer activity in primary hypercholesterolemic patients.
    Sasaki J, Yamamoto K, Kobori S, Setoguchi Y, Sato Y, Matsunaga A, Shichiri M, Sakai T, Kono S, Arakawa K.
    Int J Clin Pharmacol Ther; 1995 Jul 02; 33(7):420-6. PubMed ID: 7582401
    [Abstract] [Full Text] [Related]

  • 6. Comparative effects of two HMG-CoA reductase inhibitors (lovastatin and pravastatin) on serum lipids and lipoproteins.
    Richter WO, Jacob BG, Schwandt P.
    Int J Tissue React; 1991 Jul 02; 13(2):107-10. PubMed ID: 1955291
    [Abstract] [Full Text] [Related]

  • 7. [Long term treatment of moderate to severe hypercholesterolemia with low dose statin. Comparison of simvastatin and pravastatin].
    Spagnolli W, Ramponi C, Focher C, Dal Piaz A, Torboli P, Miori R, De Venuto G.
    Recenti Prog Med; 1996 Nov 02; 87(11):538-42. PubMed ID: 9122535
    [Abstract] [Full Text] [Related]

  • 8. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR, Gandhi S, Blasetto J, Heien H, Sasane R, Nelson SP.
    Am J Geriatr Pharmacother; 2007 Sep 02; 5(3):185-94. PubMed ID: 17996658
    [Abstract] [Full Text] [Related]

  • 9. [Effects of simvastatin on blood levels of lipoprotein (a)].
    Galetta F, Sampietro T, Basta G, Giannasi G, Bionda A.
    Minerva Med; 1995 Sep 02; 86(7-8):299-303. PubMed ID: 7478073
    [Abstract] [Full Text] [Related]

  • 10. [Effects of simvastatin on atherogenic blood lipid pattern].
    Alessandri C, Peverini F, Basili S, Barsi R, Paradiso M, Marotta P, Censi C, Cordova C, Balsano F.
    Recenti Prog Med; 1991 Apr 02; 82(4):225-9. PubMed ID: 1857842
    [Abstract] [Full Text] [Related]

  • 11. Influence of cholesterol-lowering on plasma membrane lipids and function.
    Lijnen P, Echevaría-Vázquez D, Petrov V.
    Methods Find Exp Clin Pharmacol; 1996 Mar 02; 18(2):123-36. PubMed ID: 8740244
    [Abstract] [Full Text] [Related]

  • 12. [Efficacy and tolerability of simvastatin and omega-3 fatty acid combination in patients with coronary disease, hypercholesterolemia and hypertriglyceridemia].
    Tomei R, Rossi L, Carbonieri E, Franceschini L, Cemin C, Ghebremariam-Tesfau K, Zardini P.
    Cardiologia; 1993 Dec 02; 38(12):773-8. PubMed ID: 8200011
    [Abstract] [Full Text] [Related]

  • 13. Residual effects of lovastatin and simvastatin on urinary mevalonate excretions in patients with familial hypercholesterolemia.
    Pappu AS, Bacon SP, Illingworth DR.
    J Lab Clin Med; 2003 Apr 02; 141(4):250-6. PubMed ID: 12677170
    [Abstract] [Full Text] [Related]

  • 14. Comparative effects of simvastatin and lovastatin in patients with hypercholesterolemia. The Simvastatin and Lovastatin Multicenter Study Participants.
    Farmer JA, Washington LC, Jones PH, Shapiro DR, Gotto AM, Mantell G.
    Clin Ther; 1992 Apr 02; 14(5):708-17. PubMed ID: 1468089
    [Abstract] [Full Text] [Related]

  • 15. [Swiss simvastatin multicenter study: 1. Efficacy of 10 mg simvastatin daily in patients with primary hypercholesterolemia].
    Riesen WF, Keller U, Del Bufalo A, Reutter FW, Baur HR, Golay A, Bertel O, Kummer H, Kistler H, Ammann F.
    Schweiz Med Wochenschr; 1989 Dec 02; 119(48):1719-23. PubMed ID: 2694363
    [Abstract] [Full Text] [Related]

  • 16. HMG CoA reductase inhibitors as lipid-lowering agents: five years experience with lovastatin and an appraisal of simvastatin and pravastatin.
    Maher VM, Thompson GR.
    Q J Med; 1990 Feb 02; 74(274):165-75. PubMed ID: 2111917
    [Abstract] [Full Text] [Related]

  • 17. The effects of simvastatin and pravastatin on objective and subjective measures of nocturnal sleep: a comparison of two structurally different HMG CoA reductase inhibitors in patients with primary moderate hypercholesterolaemia.
    Eckernäs SA, Roos BE, Kvidal P, Eriksson LO, Block GA, Neafus RP, Haigh JR.
    Br J Clin Pharmacol; 1993 Mar 02; 35(3):284-9. PubMed ID: 8471404
    [Abstract] [Full Text] [Related]

  • 18. Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial.
    Jones PH, Hunninghake DB, Ferdinand KC, Stein EA, Gold A, Caplan RJ, Blasetto JW, Statin Therapies for Elevated Lipid Levels Compared Across Doses to Rosuvastatin Study Group.
    Clin Ther; 2004 Sep 02; 26(9):1388-99. PubMed ID: 15531001
    [Abstract] [Full Text] [Related]

  • 19. [Comparison about the efficacy and tolerability between simvastatin and bezafibrate in the treatment of hypercholesterolemia].
    Bruckert E, Truffert J, De Gennes JL.
    Ann Med Interne (Paris); 1991 Sep 02; 142(7):505-10. PubMed ID: 1789528
    [Abstract] [Full Text] [Related]

  • 20. [Gemfibrozil reduces elevated lipoprotein (a) levels in hypercholesterolemic patients].
    Ramires JA, Spósito AC, Mansur AP, Solimene MC, Chamone D, da Luz PL, Pileggi F.
    Arq Bras Cardiol; 1997 Apr 02; 68(4):257-60. PubMed ID: 9497506
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.